FEDERATED HERMES INC (FHI) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:FHI • US3142111034

52.12 USD
-0.23 (-0.44%)
At close: Feb 6, 2026
52.12 USD
0 (0%)
After Hours: 2/6/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

Taking everything into account, FHI scores 6 out of 10 in our fundamental rating. FHI was compared to 238 industry peers in the Capital Markets industry. FHI gets an excellent profitability rating and is at the same time showing great financial health properties. FHI is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • FHI had positive earnings in the past year.
  • In the past year FHI had a positive cash flow from operations.
  • FHI had positive earnings in 4 of the past 5 years.
  • Of the past 5 years FHI 4 years had a positive operating cash flow.
FHI Yearly Net Income VS EBIT VS OCF VS FCFFHI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1.2 Ratios

  • FHI has a better Return On Assets (16.68%) than 95.82% of its industry peers.
  • Looking at the Return On Equity, with a value of 30.66%, FHI belongs to the top of the industry, outperforming 95.82% of the companies in the same industry.
  • FHI has a Return On Invested Capital of 18.60%. This is amongst the best in the industry. FHI outperforms 94.98% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for FHI is significantly above the industry average of 7.27%.
  • The last Return On Invested Capital (18.60%) for FHI is above the 3 year average (16.23%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 16.68%
ROE 30.66%
ROIC 18.6%
ROA(3y)12.38%
ROA(5y)13.04%
ROE(3y)23.49%
ROE(5y)24.27%
ROIC(3y)16.23%
ROIC(5y)16.25%
FHI Yearly ROA, ROE, ROICFHI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

  • FHI has a Profit Margin (20.80%) which is comparable to the rest of the industry.
  • FHI's Profit Margin has declined in the last couple of years.
  • FHI has a Operating Margin (28.35%) which is in line with its industry peers.
  • FHI's Operating Margin has been stable in the last couple of years.
  • The Gross Margin of FHI (95.56%) is better than 96.23% of its industry peers.
  • In the last couple of years the Gross Margin of FHI has remained more or less at the same level.
Industry RankSector Rank
OM 28.35%
PM (TTM) 20.8%
GM 95.56%
OM growth 3Y-3.42%
OM growth 5Y0.08%
PM growth 3Y-7.67%
PM growth 5Y-4.49%
GM growth 3Y-0.05%
GM growth 5Y-0.31%
FHI Yearly Profit, Operating, Gross MarginsFHI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • FHI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
FHI Yearly Shares OutstandingFHI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
FHI Yearly Total Debt VS Total AssetsFHI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

  • An Altman-Z score of 5.23 indicates that FHI is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of FHI (5.23) is better than 87.45% of its industry peers.
  • FHI has a debt to FCF ratio of 1.34. This is a very positive value and a sign of high solvency as it would only need 1.34 years to pay back of all of its debts.
  • FHI has a Debt to FCF ratio of 1.34. This is amongst the best in the industry. FHI outperforms 88.70% of its industry peers.
  • FHI has a Debt/Equity ratio of 0.29. This is a healthy value indicating a solid balance between debt and equity.
  • FHI's Debt to Equity ratio of 0.29 is fine compared to the rest of the industry. FHI outperforms 73.64% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 1.34
Altman-Z 5.23
ROIC/WACCN/A
WACCN/A
FHI Yearly LT Debt VS Equity VS FCFFHI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 3.13 indicates that FHI has no problem at all paying its short term obligations.
  • FHI has a Current ratio of 3.13. This is amongst the best in the industry. FHI outperforms 81.59% of its industry peers.
  • A Quick Ratio of 3.13 indicates that FHI has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 3.13, FHI belongs to the best of the industry, outperforming 81.59% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.13
Quick Ratio 3.13
FHI Yearly Current Assets VS Current LiabilitesFHI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 61.13% over the past year.
  • Measured over the past years, FHI shows a quite strong growth in Earnings Per Share. The EPS has been growing by 9.87% on average per year.
EPS 1Y (TTM)61.13%
EPS 3Y20.61%
EPS 5Y9.87%
EPS Q2Q%33.65%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%13.69%

3.2 Future

  • FHI is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.75% yearly.
  • FHI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.75% yearly.
EPS Next Y-0.41%
EPS Next 2Y5.34%
EPS Next 3Y5.32%
EPS Next 5Y5.75%
Revenue Next Year9.09%
Revenue Next 2Y6.68%
Revenue Next 3Y5.46%
Revenue Next 5Y1.75%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
FHI Yearly Revenue VS EstimatesFHI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B 2B
FHI Yearly EPS VS EstimatesFHI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 10.14, which indicates a very decent valuation of FHI.
  • Based on the Price/Earnings ratio, FHI is valued a bit cheaper than the industry average as 67.36% of the companies are valued more expensively.
  • FHI's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.93.
  • With a Price/Forward Earnings ratio of 10.18, the valuation of FHI can be described as very reasonable.
  • FHI's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. FHI is cheaper than 71.97% of the companies in the same industry.
  • FHI's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.77.
Industry RankSector Rank
PE 10.14
Fwd PE 10.18
FHI Price Earnings VS Forward Price EarningsFHI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of FHI indicates a rather cheap valuation: FHI is cheaper than 91.63% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, FHI is valued a bit cheaper than 69.04% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.6
EV/EBITDA 6.95
FHI Per share dataFHI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • FHI has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.03
EPS Next 2Y5.34%
EPS Next 3Y5.32%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. Dividend

5.1 Amount

  • FHI has a Yearly Dividend Yield of 2.60%.
  • FHI's Dividend Yield is comparable with the industry average which is at 6.13.
  • FHI's Dividend Yield is a higher than the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 2.6%

5.2 History

  • The dividend of FHI is nicely growing with an annual growth rate of 15.47%!
  • FHI has paid a dividend for at least 10 years, which is a reliable track record.
  • FHI has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)15.47%
Div Incr Years2
Div Non Decr Years3
FHI Yearly Dividends per shareFHI Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • FHI pays out 28.50% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of FHI is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP28.5%
EPS Next 2Y5.34%
EPS Next 3Y5.32%
FHI Yearly Income VS Free CF VS DividendFHI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
FHI Dividend Payout.FHI Dividend Payout, showing the Payout Ratio.FHI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

FEDERATED HERMES INC

NYSE:FHI (2/6/2026, 8:04:00 PM)

After market: 52.12 0 (0%)

52.12

-0.23 (-0.44%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)01-29
Earnings (Next)04-22
Inst Owners91.72%
Inst Owner ChangeN/A
Ins Owners3.46%
Ins Owner Change1.24%
Market Cap4.04B
Revenue(TTM)N/A
Net Income(TTM)363.99M
Analysts68.33
Price Target54.06 (3.72%)
Short Float %3.72%
Short Ratio4.58
Dividend
Industry RankSector Rank
Dividend Yield 2.6%
Yearly Dividend2.22
Dividend Growth(5Y)15.47%
DP28.5%
Div Incr Years2
Div Non Decr Years3
Ex-Date02-06
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.12%
Min EPS beat(2)12.16%
Max EPS beat(2)18.07%
EPS beat(4)4
Avg EPS beat(4)17.74%
Min EPS beat(4)5.9%
Max EPS beat(4)34.82%
EPS beat(8)7
Avg EPS beat(8)2.76%
EPS beat(12)10
Avg EPS beat(12)3.62%
EPS beat(16)11
Avg EPS beat(16)1.95%
Revenue beat(2)1
Avg Revenue beat(2)2.14%
Min Revenue beat(2)-0.52%
Max Revenue beat(2)4.79%
Revenue beat(4)2
Avg Revenue beat(4)0.97%
Min Revenue beat(4)-0.52%
Max Revenue beat(4)4.79%
Revenue beat(8)2
Avg Revenue beat(8)-0.28%
Revenue beat(12)4
Avg Revenue beat(12)0.44%
Revenue beat(16)6
Avg Revenue beat(16)5.28%
PT rev (1m)2.2%
PT rev (3m)3.92%
EPS NQ rev (1m)1.7%
EPS NQ rev (3m)3.47%
EPS NY rev (1m)1.14%
EPS NY rev (3m)5.24%
Revenue NQ rev (1m)0.67%
Revenue NQ rev (3m)0.67%
Revenue NY rev (1m)0.11%
Revenue NY rev (3m)1.63%
Valuation
Industry RankSector Rank
PE 10.14
Fwd PE 10.18
P/S 2.31
P/FCF 15.6
P/OCF 15.38
P/B 3.4
P/tB N/A
EV/EBITDA 6.95
EPS(TTM)5.14
EY9.86%
EPS(NY)5.12
Fwd EY9.82%
FCF(TTM)3.34
FCFY6.41%
OCF(TTM)3.39
OCFY6.5%
SpS22.56
BVpS15.31
TBVpS-0.11
PEG (NY)N/A
PEG (5Y)1.03
Graham Number42.08
Profitability
Industry RankSector Rank
ROA 16.68%
ROE 30.66%
ROCE 25.76%
ROIC 18.6%
ROICexc 28.03%
ROICexgc 434.37%
OM 28.35%
PM (TTM) 20.8%
GM 95.56%
FCFM 14.81%
ROA(3y)12.38%
ROA(5y)13.04%
ROE(3y)23.49%
ROE(5y)24.27%
ROIC(3y)16.23%
ROIC(5y)16.25%
ROICexc(3y)23.98%
ROICexc(5y)23%
ROICexgc(3y)1021.49%
ROICexgc(5y)802.2%
ROCE(3y)22.48%
ROCE(5y)22.5%
ROICexgc growth 3Y38.23%
ROICexgc growth 5Y38.01%
ROICexc growth 3Y9.02%
ROICexc growth 5Y7%
OM growth 3Y-3.42%
OM growth 5Y0.08%
PM growth 3Y-7.67%
PM growth 5Y-4.49%
GM growth 3Y-0.05%
GM growth 5Y-0.31%
F-Score7
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 1.34
Debt/EBITDA 0.67
Cap/Depr 16.6%
Cap/Sales 0.21%
Interest Coverage 250
Cash Conversion 50.71%
Profit Quality 71.2%
Current Ratio 3.13
Quick Ratio 3.13
Altman-Z 5.23
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)21%
Cap/Depr(5y)28.99%
Cap/Sales(3y)0.35%
Cap/Sales(5y)0.55%
Profit Quality(3y)126.81%
Profit Quality(5y)111.36%
High Growth Momentum
Growth
EPS 1Y (TTM)61.13%
EPS 3Y20.61%
EPS 5Y9.87%
EPS Q2Q%33.65%
EPS Next Y-0.41%
EPS Next 2Y5.34%
EPS Next 3Y5.32%
EPS Next 5Y5.75%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%13.69%
Revenue Next Year9.09%
Revenue Next 2Y6.68%
Revenue Next 3Y5.46%
Revenue Next 5Y1.75%
EBIT growth 1Y-7.04%
EBIT growth 3Y4.23%
EBIT growth 5Y4.35%
EBIT Next Year51.75%
EBIT Next 3Y16.94%
EBIT Next 5Y9.5%
FCF growth 1Y-16%
FCF growth 3Y28.89%
FCF growth 5Y1.38%
OCF growth 1Y-16.45%
OCF growth 3Y26.7%
OCF growth 5Y0.69%

FEDERATED HERMES INC / FHI FAQ

Can you provide the ChartMill fundamental rating for FEDERATED HERMES INC?

ChartMill assigns a fundamental rating of 6 / 10 to FHI.


What is the valuation status for FHI stock?

ChartMill assigns a valuation rating of 6 / 10 to FEDERATED HERMES INC (FHI). This can be considered as Fairly Valued.


How profitable is FEDERATED HERMES INC (FHI) stock?

FEDERATED HERMES INC (FHI) has a profitability rating of 7 / 10.


What is the valuation of FEDERATED HERMES INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for FEDERATED HERMES INC (FHI) is 10.14 and the Price/Book (PB) ratio is 3.4.


Is the dividend of FEDERATED HERMES INC sustainable?

The dividend rating of FEDERATED HERMES INC (FHI) is 5 / 10 and the dividend payout ratio is 28.5%.